Hydrochlorothiazide and Triamterene Articles
Goldshield buys SB products for L17 mill
8 July 1999
Mylan Receive Approval For Generic Dyazide
24 June 1996
US PRODUCT NEWS IN BRIEF
18 April 1994
THE FUTURE FOR THE US DRUG MARKET
28 February 1994
VITARINE FINED OVER DYAZIDE
11 October 1993
SB BEECHAM RESULTS; EXPLOITS STRENGTHS
1 March 1993
BOLAR FOUNDER SENTENCED
1 February 1993
BOLAR PHARMA IN US TRIAL
4 January 1993
Showing 1-8 of 8 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Italy's pharma market slump set to continue, warns GlobalData
- Pfizer to split-off remaining 80% interest in Zoetis
